• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Can Coronary Artery Involvement in Kawasaki Disease be Predicted?川崎病冠状动脉受累能否预测?
Diagnostics (Basel). 2013 Mar 26;3(2):232-43. doi: 10.3390/diagnostics3020232.
2
Relationship between mean platelet volume-to-lymphocyte ratio and coronary artery abnormalities in Kawasaki disease.川崎病中平均血小板体积与淋巴细胞比值和冠状动脉异常的关系。
Cardiol Young. 2018 Jun;28(6):832-836. doi: 10.1017/S1047951118000422. Epub 2018 Apr 16.
3
Risk of coronary artery involvement in Kawasaki disease.川崎病冠状动脉受累的风险。
Arch Argent Pediatr. 2016 Apr;114(2):107-13. doi: 10.5546/aap.2016.eng.107. Epub 2016 Feb 5.
4
[Predicting value of thrombospondin-2 for coronary artery dilatation in patients with Kawasaki disease].[血小板反应蛋白-2对川崎病患者冠状动脉扩张的预测价值]
Zhonghua Er Ke Za Zhi. 2016 Apr;54(4):259-63. doi: 10.3760/cma.j.issn.0578-1310.2016.04.006.
5
Utilization of Coronary Artery to Aorta for the Early Detection of Kawasaki Disease.利用冠状动脉至主动脉来早期检测川崎病。
Pediatr Cardiol. 2019 Mar;40(3):461-467. doi: 10.1007/s00246-018-1985-6. Epub 2018 Sep 14.
6
Clinical relevance of the risk factors for coronary artery inflammation in Kawasaki disease.川崎病冠状动脉炎症危险因素的临床相关性
Pediatr Cardiol. 2003 Mar-Apr;24(2):122-6. doi: 10.1007/s00246-002-0063-1. Epub 2002 Dec 4.
7
Coronary artery involvement in children with Kawasaki disease: risk factors from analysis of serial normalized measurements.川崎病患儿的冠状动脉受累情况:基于系列标准化测量分析的危险因素
Circulation. 2007 Jul 10;116(2):174-9. doi: 10.1161/CIRCULATIONAHA.107.690875. Epub 2007 Jun 18.
8
Retrospective study of the course, treatment and long-term follow-up of Kawasaki disease: a single-center experience from Poland.回顾性研究川崎病的病程、治疗和长期随访:波兰单中心经验。
Rheumatol Int. 2019 Jun;39(6):1069-1076. doi: 10.1007/s00296-019-04286-9. Epub 2019 Mar 22.
9
Clinical spectrum of Kawasaki disease in infants.婴儿川崎病的临床谱
Zhonghua Yi Xue Za Zhi (Taipei). 2001 Mar;64(3):168-73.
10
Delayed intravenous immunoglobulin treatment increased the risk of coronary artery lesions in children with Kawasaki disease at different status.延迟静脉注射免疫球蛋白治疗增加了不同状态川崎病患儿冠状动脉病变的风险。
Postgrad Med. 2018 May;130(4):442-447. doi: 10.1080/00325481.2018.1468712. Epub 2018 May 10.

引用本文的文献

1
Kawasaki disease - often a diagnostic dilemma in pediatric population: a case report.川崎病——儿科人群中常面临的诊断难题:一例病例报告
Ann Med Surg (Lond). 2023 Apr 7;85(5):2037-2040. doi: 10.1097/MS9.0000000000000472. eCollection 2023 May.
2
An Update on Reports of Atypical Presentations of Kawasaki Disease and the Recognition of IVIG Non-Responder Children.川崎病非典型表现报告及静脉注射免疫球蛋白无反应儿童识别的最新进展
Diagnostics (Basel). 2023 Apr 17;13(8):1441. doi: 10.3390/diagnostics13081441.
3
Multisystem inflammatory syndrome in children and Kawasaki disease: a critical comparison.儿童多系统炎症综合征与川崎病:关键对比。
Nat Rev Rheumatol. 2021 Dec;17(12):731-748. doi: 10.1038/s41584-021-00709-9. Epub 2021 Oct 29.
4
Risk Factors of Coronary Artery Abnormality in Children With Kawasaki Disease: A Systematic Review and Meta-Analysis.川崎病患儿冠状动脉异常的危险因素:系统评价与Meta分析
Front Pediatr. 2019 Sep 26;7:374. doi: 10.3389/fped.2019.00374. eCollection 2019.
5
Acute Kawasaki disease with emphasis on the echocardiographic profile: A single center experience.以超声心动图特征为重点的急性川崎病:单中心经验
Glob Cardiol Sci Pract. 2017 Oct 31;2017(3):e201727. doi: 10.21542/gcsp.2017.27.

本文引用的文献

1
Can fibroblast growth factor (FGF)-23 circulating levels suggest coronary artery abnormalities in children with Kawasaki disease?成纤维细胞生长因子 23(FGF-23)的循环水平能否提示川崎病患儿存在冠状动脉异常?
Clin Exp Rheumatol. 2013 Jan-Feb;31(1):149-53. Epub 2013 Jan 16.
2
Inflammation-induced hepcidin is associated with the development of anemia and coronary artery lesions in Kawasaki disease.炎症诱导的铁调素与川崎病贫血和冠状动脉病变的发展有关。
J Clin Immunol. 2012 Aug;32(4):746-52. doi: 10.1007/s10875-012-9668-1. Epub 2012 Mar 6.
3
Increased incidence of incomplete Kawasaki disease at a pediatric hospital after publication of the 2004 American Heart Association guidelines.2004年美国心脏协会指南发布后,一家儿科医院不完全川崎病的发病率增加。
Pediatr Cardiol. 2012 Oct;33(7):1097-103. doi: 10.1007/s00246-012-0232-9. Epub 2012 Feb 15.
4
A half-century of autopsy results--incidence of pediatric vasculitis syndromes, especially Kawasaki disease.半个世纪的尸检结果——儿科血管炎综合征的发病率,特别是川崎病。
Circ J. 2012;76(4):964-70. doi: 10.1253/circj.cj-11-0928. Epub 2012 Feb 7.
5
Clinical relevance of the risk factors for coronary artery lesions in Kawasaki disease.川崎病冠状动脉病变相关危险因素的临床意义。
Kaohsiung J Med Sci. 2012 Jan;28(1):23-9. doi: 10.1016/j.kjms.2011.09.002. Epub 2011 Dec 11.
6
Histo-blood group gene polymorphisms as potential genetic modifiers of the development of coronary artery lesions in patients with Kawasaki disease.组织血型基因多态性作为川崎病患者冠状动脉病变发展的潜在遗传修饰因子。
Int J Immunogenet. 2012 Apr;39(2):119-25. doi: 10.1111/j.1744-313X.2011.01065.x. Epub 2011 Nov 25.
7
Assessment of risk factors for Korean children with Kawasaki disease.韩国川崎病患儿危险因素评估。
Pediatr Cardiol. 2012 Apr;33(4):513-20. doi: 10.1007/s00246-011-0143-1. Epub 2011 Nov 22.
8
Genome-wide association study identifies FCGR2A as a susceptibility locus for Kawasaki disease.全基因组关联研究发现 FCGR2A 是川崎病的易感基因位点。
Nat Genet. 2011 Nov 13;43(12):1241-6. doi: 10.1038/ng.981.
9
A meta-analysis of the biomarkers associated with coronary artery lesions secondary to Kawasaki disease in Chinese children.中国儿童川崎病继发冠状动脉病变相关生物标志物的荟萃分析。
J Huazhong Univ Sci Technolog Med Sci. 2011 Oct;31(5):705. doi: 10.1007/s11596-011-0587-9. Epub 2011 Oct 25.
10
ITPKC and CASP3 polymorphisms and risks for IVIG unresponsiveness and coronary artery lesion formation in Kawasaki disease.ITPKC 和 CASP3 多态性与川崎病免疫球蛋白静脉注射无反应和冠状动脉损伤形成的风险。
Pharmacogenomics J. 2013 Feb;13(1):52-9. doi: 10.1038/tpj.2011.45. Epub 2011 Oct 11.

川崎病冠状动脉受累能否预测?

Can Coronary Artery Involvement in Kawasaki Disease be Predicted?

机构信息

Division of Cardiology, Children's National Medical Center, Washington, DC 20010, USA.

Department of Diagnostic Imaging and Radiology, Children's National Medical Center, Washington, DC 20010, USA.

出版信息

Diagnostics (Basel). 2013 Mar 26;3(2):232-43. doi: 10.3390/diagnostics3020232.

DOI:10.3390/diagnostics3020232
PMID:26835677
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4665533/
Abstract

BACKGROUND

Coronary artery involvement is seen in approximately 15-20% of children with Kawasaki disease. There is conflicting literature regarding the clinical and laboratory findings associated with coronary artery involvement. In this retrospective study, we attempt identification of predictive factors for coronary artery involvement at our institute and review the existing literature.

METHODS AND RESULTS

A review of 203 patients (65% males) with Kawasaki disease was performed, of whom 33 (16.3%) had coronary artery involvement. High erythrocyte sedimentation rate, high platelet count, low hematocrit, low albumin levels, and refractory Kawasaki disease showed significant association with coronary artery involvement. High erythrocyte sedimentation rate and refractory Kawasaki disease were found to be independent predictors of coronary artery involvement. Review of literature suggested a wide range of coronary involvement (<5% to >60%), and highly conflicting clinical and laboratory associations.

CONCLUSION

It remains difficult to accurately determine risk of coronary artery involvement, although some laboratory markers may provide information that is helpful for parental counseling and clinical follow up. Future identification of novel biomarkers and host predispositions may further our understanding of coronary artery risks and help personalize therapy for Kawasaki disease.

摘要

背景

约 15-20%的川崎病患儿存在冠状动脉受累。关于与冠状动脉受累相关的临床和实验室发现,文献存在争议。在这项回顾性研究中,我们试图确定本研究所的冠状动脉受累的预测因素,并复习现有文献。

方法和结果

对 203 例(男性占 65%)川崎病患者进行了回顾性分析,其中 33 例(16.3%)存在冠状动脉受累。高红细胞沉降率、高血小板计数、低血细胞比容、低白蛋白水平和难治性川崎病与冠状动脉受累有显著相关性。高红细胞沉降率和难治性川崎病是冠状动脉受累的独立预测因素。文献复习表明,冠状动脉受累范围广泛(<5%至>60%),且临床和实验室相关性存在很大争议。

结论

尽管某些实验室标志物可能提供有助于家长咨询和临床随访的信息,但仍难以准确确定冠状动脉受累的风险。未来对新型生物标志物和宿主易感性的识别可能有助于进一步了解冠状动脉风险,并有助于川崎病的个体化治疗。